Keywords: mgi, pharma, prices, 6m, offering, oncology-focused, biopharmaceutical

MGI Pharma prices $146.6M offering

Article | 18 August 2003

Print This

MGI Pharma, an oncology-focused biopharmaceutical company, has announced the pricing of a public offering of 4.4 million shares of its common ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in